Abnormal Circulating C Peptide Concentration C4280765
C-peptide is released with insulin and shows how much insulin the body produces. Abnormal levels help differentiate between type 1 and type 2 diabetes and assess insulin production. Treatment depends on the diabetes type and severity.
Key facts at a glance
- ICD-10
- E34.9
- ICD-11
- 5A00.0
- Body system
- endocrine
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Loss of consciousness
Fainting or passing out, often related to severe blood sugar fluctuations.
Seek immediate emergency care if someone loses consciousness
Seizures
Involuntary muscle movements and loss of awareness due to severe hypoglycemia.
Seek immediate emergency care for any seizure activity
Fatigue
(constitutional)Persistent tiredness and lack of energy that interferes with daily activities.
Frequency: 70-80% of patients
Difficulty concentrating
(neurologic)Trouble focusing, mental fog, or reduced ability to perform complex tasks.
Frequency: 65-75% of patients
Excessive sweating
(autonomic)Unusual sweating, especially at night or without obvious cause.
Frequency: 60-70% of patients
Palpitations
(cardiovascular)Awareness of rapid, strong, or irregular heartbeat.
Frequency: 40-50% of patients
Tremor
(neurologic)Shaking or trembling, often noticeable in the hands.
Frequency: 35-45% of patients
Increased hunger
(gastrointestinal)Excessive feeling of hunger, even after eating meals.
Frequency: 40-50% of patients
Dizziness
(neurologic)Feeling of lightheadedness, unsteadiness, or faintness.
Frequency: 30-40% of patients
Blurred vision
(neurologic)Temporary vision changes or difficulty focusing clearly.
Frequency: 20-30% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Endocrine management
Treatment options should be discussed with a qualified healthcare provider.
Glucose regulation through exercise
Regular physical activity improves insulin sensitivity and helps regulate blood glucose levels, which can normalize C-peptide production. Moderate aerobic exercise 150 minutes weekly combined with resistance training is recommended.
Carbohydrate-controlled meal planning
Structured carbohydrate intake with consistent timing helps stabilize insulin secretion and C-peptide levels. Focus on low glycemic index foods and balanced macronutrient distribution throughout the day.
Additional treatment options
Insulin sensitizing agents
Medications that improve cellular response to insulin may help normalize C-peptide levels when lifestyle measures are insufficient. Treatment selection depends on underlying etiology and overall metabolic profile.
medicationMetabolic laboratory tracking
Serial measurements of C-peptide alongside glucose levels help assess treatment response and guide therapeutic adjustments. Monitoring frequency depends on clinical stability and treatment changes.
monitoringStress management techniques
Chronic stress elevates cortisol and affects glucose metabolism, indirectly influencing C-peptide levels. Mind-body practices such as meditation and breathing exercises support overall metabolic balance.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Circulating C Peptide Concentration C4280765?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl_1):S19-S40.
Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med. 2013;30(7):803-817.
World Health Organization. Classification of Diabetes Mellitus 2019. Geneva: World Health Organization; 2019.
American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl_1):S83-S96.
Leighton E, Sainsbury CA, Jones GC. A Practical Review of C-Peptide Testing in Diabetes. Diabetes Ther. 2017;8(3):475-487.
Palmer JP, Fleming GA, Greenbaum CJ, et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2004. Diabetes. 2004;53(1):250-264.
Bogun MM, Bundy BN, Goland RS, Greenbaum CJ. C-Peptide Levels in Subjects With Newly Diagnosed Type 1 Diabetes Before and After Immunotherapy. J Clin Endocrinol Metab. 2020;105(3):dgz204.
Melmed S, Polonsky KS, Larsen PR, Kronenberg HM. Williams Textbook of Endocrinology. 14th ed. Philadelphia: Elsevier; 2019.
International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2022. Pediatr Diabetes. 2022;23(8):1179-1199.
Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2022. Atlanta, GA: CDC; 2022.
Medication Comparisons
Compare medications used to treat Abnormal Circulating C Peptide Concentration C4280765. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy